Onesource Specialty Pharma Limited — Others, 07-07-2025: Appointment

OneSource Specialty Pharma Limited has announced a board meeting and approved the appointment of Jeffrey Wong as Chief Business Officer. With over 30 years of global experience in biopharma, Jeffrey has led key roles in biologics manufacturing, regulatory approvals, and commercial growth at firms like Syngene International, Fujifilm Diosynth, and Thermo Fisher. His expertise spans bioprocess products and CDMO services, focusing on innovative biologic therapies and strategic partnerships. Jeffrey’s leadership and industry insight are expected to strengthen OneSource’s commercial capabilities and growth trajectory.